Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cocrystal Pharma Inc. July 14, 202691.7%
-
OPKO Health Inc. June 18, 202691.5%
-
Fluent Inc. June 17, 202699.2%
-
Cocrystal Pharma Inc. June 25, 202596.4%
-
Fluent Inc. June 18, 202596.9%
-
OPKO Health Inc. April 23, 202598.7%
-
Cocrystal Pharma Inc. June 25, 202482.6%
-
GeneDx Holdings Corp. June 20, 202496.8%
-
Fluent Inc. June 5, 202495.6%
-
OPKO Health Inc. March 28, 202494.1%
-
OPKO Health Inc. June 22, 202382.2%
-
Fluent Inc. June 9, 202378.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | GeneDx Holdings Corp. | Option exercise | +3,576 | — | — |
| Jun 17, 2026 | Fluent Inc. | Grant or award | +30,096 | — | — |
| Oct 28, 2025 | Cocrystal Pharma Inc. | Grant or award | +20,000 | — | — |
| Jun 18, 2025 | GeneDx Holdings Corp. | Option exercise | +12,924 | — | — |
| Jun 18, 2025 | Fluent Inc. | Grant or award | +39,682 | — | — |
| May 2, 2025 | GeneDx Holdings Corp. | Option exercise | +918 | — | — |
| Oct 9, 2024 | Cocrystal Pharma Inc. | Grant or award | +8,067 | — | — |
| Jun 20, 2024 | GeneDx Holdings Corp. | Option exercise | +5,828 | — | — |
| Jun 5, 2024 | Fluent Inc. | Grant or award | +21,429 | — | — |
| May 2, 2024 | GeneDx Holdings Corp. | Option exercise | +918 | — | — |
| Jan 5, 2024 | OPKO Health Inc. | Open-market purchase | +13,000 | $0.93 | $12,090 |
| Jan 5, 2024 | OPKO Health Inc. | Open-market purchase | +12,000 | $0.95 | $11,400 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
Questions about Richard C. Pfenniger Jr.
What boards is Richard C. Pfenniger Jr. on?
Richard C. Pfenniger Jr. sits on the boards of Cocrystal Pharma Inc., Fluent Inc., GeneDx Holdings Corp. and OPKO Health Inc.
How long has Richard C. Pfenniger Jr. served on boards?
Our records show at least 14 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.